Prism Finance is a non-banking financial company that primarily engages in proprietary stock market trading, derivatives, and providing inter-corporate loans to related parties.
The company lacks a competitive advantage as its income is entirely dependent on market fluctuations of its investment portfolio and interest from related-party loans. The negative net margins and low ROCE confirm the absence of any pricing power or structural edge.
Capital is primarily deployed into a concentrated portfolio of equity securities and loans to entities associated with the directors. This strategy has resulted in significant volatility and a net loss in the most recent fiscal year.
The company's collapse was driven by the inevitable crystallization of its 'related-party' loan book and the forced liquidation of its concentrated, illiquid equity portfolio. As the insolvency proceedings for its major investments dragged on without recovery, the qualified audit opinions turned into massive write-downs that wiped out the remaining book value. The lack of a Managing Director left the firm rudderless during a credit crunch, and the disputed tax liabilities for undisclosed income finally came due, draining the last of the cash reserves while the internal control weaknesses prevented any timely pivot or recovery.
RichFakir rates Prism Finance Ltd's business quality as poor — 6/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Prism Finance Ltd is trading about 1% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Prism Finance Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Prism Finance Ltd's fair value is about ₹24 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →